US2019382488A1PendingUtilityA1

Antigen binding constructs to cd8

72
Assignee: IMAGINAB INCPriority: Mar 13, 2013Filed: May 20, 2019Published: Dec 19, 2019
Est. expiryMar 13, 2033(~6.7 yrs left)· nominal 20-yr term from priority
Inventors:David T. HoTove OlafsenGiti AgahiChristian Behrenbruch
A61K 51/1027A61K 47/6849C07K 2317/24C07K 16/2815C07K 2317/622C07K 2317/624C07K 2317/92C07K 2317/626G01N 2333/70517C07K 2317/31C07K 2317/56C07K 2317/565G01N 33/6872A61K 2039/505C07K 2317/35G01N 33/566
72
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Antigen binding constructs that bind to CD8, for example antibodies, including antibody fragments (such as scFv, minibodies, and cys-diabodies) that bind to CD8, are described herein. Methods of use are described herein.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . A polypeptide, the amino acid sequence of which is SEQ ID NO: 16.

Join the waitlist — get patent alerts

Track US2019382488A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.